Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Mitapivat sulfate by Agios Pharmaceuticals for Beta Thalassaemia: Likelihood of Approval
Mitapivat sulfate is under clinical development by Agios Pharmaceuticals and currently in Phase III for Beta Thalassaemia. According to GlobalData,...
Data Insights
Mitapivat sulfate by Agios Pharmaceuticals for Alpha Thalassaemia: Likelihood of Approval
Mitapivat sulfate is under clinical development by Agios Pharmaceuticals and currently in Phase III for Alpha Thalassaemia. According to GlobalData,...